Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor JPN)
Clinical trial NCT01943461 · COMPLETED
Trial details
- NCT number
- NCT01943461
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-02
- Primary completion
- 2015-01-07
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.